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Recurrent pregnancy loss (RPL) is defined as two or more consecutive miscarriages 
and affects an estimated 1.5% of couples trying to conceive. RPL has been attributed to 
genetic, endocrine, immune and thrombophilic disorders, But many cases remain 
unexplained. We investigated a Bangladeshi family where the proband experienced 29 
consecutive pregnancy losses with no successful pregnancies from three different marriages. 
Whole exome sequencing identified rare genetic variants in several candidate genes. These 
were further investigated in Asian and White European RPL cohorts, and in Bangladeshi 
controls. FKBP4, encoding the immunophilin FK506 binding protein 4, was identified as a 
plausible candidate, with three further novel variants identified in Asian patients. None were 
found in European patients or controls. In silico structural studies predicted damaging effects 
of the variants in the structure-function properties of the FKBP52 protein. These were located 
domains reported to be involved in Hsp90 binding and peptidyl-prolyl cic-trans isomerase 
(PPIase) activity. Profound effects on PPIase activity were demonstrated in transiently 
transfected HEK293 cells comparing wildtype and mutant FKBP4 constructs. Mice lacking 
Fkbp4 have been previously reported as infertile through implantation failure. This study 
therefore strongly implicates FKBP4 as associated with fetal losses in humans, particularly in 
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Miscarriage is the commonest complication of pregnancy and it is defined as the 
spontaneous loss of a fetus before it has reached viability
1
. Studies have shown that the risk 
of a pregnancy loss increases after each successive miscarriage and can reach as high as 45% 
after three consecutive losses
2
. A diagnosis of recurrent pregnancy loss (RPL) is usually 
considered following the loss of at least two pregnancies and has been attributed to many risk 
factors as parental age or lifestyle factors, as well as genetic causes such as chromosomal 
abnormalities, anatomical disorders including uterine abnormalities and endocrine defects
3
. 
Moreover, RPL can be caused by abnormalities in the immune system, for example the 
antiphospholipid syndrome (APLS)
3
 or thrombophilic disorders leading to thrombosis, 
caused for example by the Factor V Leiden mutation (FVL)
3,4
. However, for many patients, 
the cause of RPL remains a clinical dilemma, since even after detailed investigation their 
miscarriages remain unexplained, which is traumatic for patients
3
. 
Here we describe a genomic approach to identify a new candidate gene for RPL. This 
study focused on a single family from Bangladesh where the patient suffered a total of 29 
early RPLs, before the 12
th
 week of gestation, all of whom were unexplained. We performed 
whole-exome sequencing in the family members, which led to the identification of two 
candidate genes with variants in the proband. These candidate genes FKBP4 (encoding 
FK506 binding protein 4, also known as FKBP52) and SERPINB2 (serpin peptidase inhibitor 
clade b2) were investigated in greater depth by sequencing them in cohorts of Asian RPL 
(n=100) and White European RPL (n=120) patients, all of which had no successful 
pregnancies, as well as in a normal Bangladeshi cohort. Three novel variants were identified 
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FKBP52 is common to several vertebrate species and the respective mRNA 
transcripts are expressed in a variety of human tissues such as brain, heart and placenta
5
. 
FKBP52 has been described as a co-chaperone for steroid hormone nuclear receptors and 
binds to the progesterone receptor (PR) to optimise progesterone-PR signalling. Therefore 
success of transcriptional activation depends on the binding of PR to FKBP52. Female mice 
lacking the Fkbp4 gene have compromised PR functions leading to a total failure of the 
uterus to support blastocyst implantation
6-8
, strongly supporting the candidacy of FKBP4 for 
a role in RPL. We conclude that FKBP4 is a novel candidate gene associated with RPL in 
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The family pedigree 
The patient (II-3) and her family (Fig. 1) originate from Bangladesh but live in 
London. The family is under the care of the Recurrent Miscarriage team at St Mary’s 
Hospital, Imperial College London. This patient, who is now 46 years old, had a total of 29 
pregnancy losses all of which were early, between 9-11 weeks of gestation, with no live 
births. She had 17 miscarriages with her first husband (II-1), five miscarriages with her 
second husband (II-2) and seven miscarriages with her third husband (II-4). All of these 
pregnancies were naturally conceived and the miscarriages were unexplained as the patient 
tested normal for APLS and lupus anticoagulant (LA) and negative for the FVL mutation. 
The patient’s mother had three successful pregnancies and three late miscarriages all of 
which were in the second or third trimester. The patient’s brothers (II-5 and II-6), each had 
two healthy children. 
FKBP4 variants in recurrent miscarriage patients 
We performed whole-exome sequencing (WES) in the proband as well as her third 
husband and her two brothers. Following comprehensive variant analyses and prioritization, 
two genes with novel variants present only in the proband were identified. The model we 
used was a dominant model that considered the RPL patient as an affected individual and her 
two brothers and husband as unaffected. WES data from four Asian females provided by 
Great Ormond Street Hospital’s Centre for translational research (GOSgene) were used as 
additional unaffected controls in this analysis. 
After excluding common variants that were present more than 1% in public databases 
and including variants that are predicted to be possibly pathogenic by in silico tools, two 
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c.47C>A (Ala16Glu) in FKBP4 at position chr12:2904352 and a rare missense heterozygous 
change c.328C>G (Leu110Val) in SERPINB2 at position chr18:61564364. Both variants 
were confirmed by Sanger sequencing. Segregation analysis was performed by PCR and 
Sanger sequencing in the parents. This revealed that both variants were inherited from the 
patient’s father. Coding regions of these genes were completely sequenced in two larger RPL 
cohorts (100 Asians and 120 White-Europeans) that had no successful pregnancies, as well as 
a control cohort of 100 Bangladeshi mothers who had no previous history of miscarriage and 
at least one successful pregnancy. While no further missense variants present exclusively in 
patients were identified in SERPINB2, three more heterozygous missense variants were 
identified in FKBP4 in the Asian RPL cohort, which were not present in the RPL White-
Europeans or the Bangladeshi controls tested. The missense variants detected in three 
different Asian patients were: c.374A>G (Asn125Ser) at position chr12:29047018, 
c.1142A>T (Gln381Leu) at position chr12:2910392 and c.1196G>A (Arg399Gln) at position 
chr12:2910446. A list of all the variants identified in both FKBP4 and SERPINB2 in our 
control and RPL cohorts with population frequency data from gnomAD (v2.1.1) is shown in 
Supplementary Table 1. Overall, a statistically significant difference was observed between 
Asian RPL patients and Bangladeshi fertile controls (chi-squared test; p=0.04). 














). All the variants were predicted to be pathogenic by multiple 
programmes. Amino acid sequence conservation across different species was investigated 
using Clustal W2
16
, a multiple sequence alignment program for DNA or proteins. This 
protein shows a high degree of conservation between species and the four variant residues are 
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variants in FKBP4, pathogenicity predictions of different online tools, as well as protein 
conservation are shown in Figure 2. 
Structural and functional effects of FKBP52 missense variants 
FKBP52 is a member of the immunophilin protein family FK506-binding proteins, 
which are based on their ability to bind to the immunosuppressive drug FK506 (Tacrolimus). 
Human FKBP52 is composed of four distinct and functional domains, which have been 
previously described
17-28
. A16E and N125S variants are located in Domain I, whereas Q381L 
and R399Q are located in Domain III (Fig. 3).  Structural studies were undertaken to predict 
damaging effects in the structure-function properties of FKBP52 (Fig. 4).  
Although A16E, was not amenable to accurate structural modelling due to the lack of 
known structural information for this region, the N125S mutation occurs in FK1, in a loop 
that is part of the peptidyl-prolyl cis-trans isomerase (PPIase) active site. This loop also binds 
rapamycin and FK506 by closing over the drug-binding pocket and makes multiple contacts 
with the drug. This loop has four conserved prolines and its conformation is likely to be 
important for PPIase activity, receptor binding and potentiation. Mutation of P119L in 
FKBP52 has previously been shown to dramatically reduce signaling compared to wild-type 
FKBP52
25
 and mutation of FKBP12 amino acids 89 and 90 (equivalent to positions 120 and 
121 in FKBP52) in the loop region, disrupted binding of FKBP12 to the TGF-β receptor. 
Further, deletion of the PPIase domain eliminates FKBP52’s ability to enhance receptor 
function
25
. The drug FK506, which binds the PPIase active site and inhibits enzymatic 
activity, inhibits FKBP52-dependent potentiation of receptor function in yeast
26
. However, 
PPIase activity per se is not required for potentiation. By analogy to other well-characterized 
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It is proposed that FKBP52 FK1 forms a specific contact with the receptor ligand 
binding domain (LBD) of Heat shock protein 90 (Hsp90) heterocomplexes via the notch 
formed by P119 in the overhanging loop. This contact potentiates receptor responses to 
hormone
28
. Also, interaction with the LBD is likely weak, while Hsp90 interaction stabilizes 
a dynamic LBD conformational state that otherwise is transiently favorable for hormone 
binding. N125 forms a hydrogen bond with S115 and this interaction is not present in the 
rapamycin (and FK506) bound forms of FKBP52 suggesting that this interaction might help 
in mediating the conformational changes required in the loop for interaction with partner 
receptors and for PPIase activity (Fig. 4a). 
The Q381 variant is located at the end of helix 6 while R399 is located in the helix 7 
at the C-terminal of the tetratricopeptide (TPR) domain (Fig 4b). The core TPR domain and 
the helix H7 extension at least up to residue 414 were shown to be essential for Hsp90 
binding and assembly into receptor complexes
28
. Despite retention of the core TPR domain, 
deletion of residues beyond 406 abrogates Hsp90 binding and PR association. Additionally, 
the final 30 amino acids of FKBP51 enhance binding to Hsp90, whereas the corresponding 
region of FKBP52 moderates binding to Hsp90. The H7 helix of FKBP52 shifts away by 30° 
from the Hsp90-binding interface relative to FKBP51. With respect to the R399Q variant, 
R399 is at the site where the helix 7 begins to shift away from the conformation in FKBP51, 
reflecting a probable role in maintaining the structure of this region. Both R399 and Q381 are 
found at the interface between different FKBP52 monomers in the crystal structure
29
. But 
there have been no clear experimental evidence to support the multimerization state of 
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surface while Q381L replaces a polar side chain with a hydrophobic group potentially 
affecting the interactions mediated by these two residues (Fig. 4c).  
 The region of FKBP52 located between aa 267 and 400, which includes the TPR 
domain, is also required for tubulin binding
23
. FKBP52 can have multiple tubulin binding 
sites based on the observation that the deletion mutants with segments 1-375 and 375-458 
both bind tubulin. FKBP52 prevents tubulin polymerization and the 84 residue sequence 
located in the C-terminal part of the molecule (aa 375–458) is necessary and sufficient for its 
microtubule de-polymerization activity, although with lower efficiency.  
Next, the functional effects of each variant were tested in a transient overexpression 
assay measuring PPIase activity
9
 (Fig. 5). Minimal endogenous PPIase activity was initially 
detected in HEK293 cells (data not shown). HEK293 cells were then transfected with 
wildtype (WT) and mutant FKBP52 constructs, each representing sequence variants 
identified in the RPL patients described above as well as empty vector an mock transfected 
controls. The WT construct showed a highly significant, 3-fold higher PPlase activity than 
empty vector or mock transfected cells (p=<0.002). The N125S mutant, located in the PPIase 
active site showed reduced activity compared to the controls which was significantly 
(p=<0.0001) less than the WT construct. The other three variants tested, A16E, Q381L and 
R399Q all showed similar activity to controls, again, all significantly (p=<0.002) reduced 
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Infertility and spontaneous pregnancy losses are sadly a common outcome for many 
women. The establishment of pregnancy depends on successful implantation, where a 
complex series of interactions occur between the uterus and blastocyst. Multiple early 
pregnancy loss is a significant clinical problem for women and their health care providers. 
In this study, a woman with an unusually severe history of miscarriages was 
investigated. Exome sequencing was carried out and led to the identification of a missense 
variant in the FKBP4 gene of the female patient, which was not present in the patient’s 
husband, brothers or the four unrelated Asian female controls used in the prioritization. 
Segregation analysis was performed by PCR and Sanger sequencing in the patient’s parents. 
This revealed that the variant was inherited from the father. This would be consistent with 
an inheritance model that suggests that the RPL effect is primarily expressed in the mother, 
perhaps creating an environment that is not compatible with implantation. A maternal effect 
is described when an offspring shows the phenotype expected from the genotype of the 
mother, irrespective of its own genotype. This can be due to the mother supplying gene 
products (mRNA or proteins) to the embryo
30
. Functional studies have reported the essential 
role of these products during gametogenesis and early embryonic development
31
. Loss of 
their function has no effect on male offspring or their fertility, or on the females offspring 
themselves, but females are sterile because their oocytes do not support early development. 
Maternal mRNAs accumulated in the oocyte play a critical role for successful development 




Although Fkbp4 heterozygous null animals were all fertile and without reproductive 
failures, both male and female homozygous mice, were reported to be infertile, highlighting 
the importance of FKBP52 in reproduction
6
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produce viable spermatozoa but had defects in reproductive tissues consistent with androgen 
insensitivity. Female null mice were anatomically normal but infertility was found to be a 
consequence of either implantation failure or pregnancy loss following implantation, which 
was associated with impaired progesterone function
7
. While this implantation failure 
phenotype was observed in both CD1 and C57BL6/129 knockout mice, daily progesterone 
supplementation rescued implantation with subsequent decidualization in CD1 Fkbp4
-/-
 
females but was ineffective in rescuing implantation in C57BL6/129 Fkbp4
-/-
 females 
demonstrating the importance of genetic background
7. 
 
Further experiments showed that uterine levels of an antioxidant, peroxiredoxin-6 
(PRDX6) were significantly lower in Fkbp4
-/-
 mice and that these mice having reduced 
uterine PRDX6 levels were susceptible to oxidative stress leading to implantation failure 
even with progesterone supplementation
8
. FKBP52 may also promote endometriosis, as 
women with endometriosis show reduced FKBP52 expression and the progesterone 
resistance observed in the FKBP52 deficient mice results in increased inflammation, cell 
proliferation and angiogenesis which encourages the growth of endometriotic lesions. This 
suggests a vital role of FKBP52 in female reproduction and uterine signalling
33
.  
FKBP52 is a member of the immunophilin protein family, which is known for their 
roles in immunoregulation and basic cellular processes involving protein-protein interaction, 
protein folding and trafficking. FKBPs range in size from 12 to 135kDa
34 
but all share a 
common domain for immunosuppressant ligand binding. However, they differ in their FK506 
affinity, in other domain structures and their subcellular localization, suggesting that each 
FKBP may have a distinct function
23
. Human FKBP52 is composed of four distinct 
functional domains (shown in Fig. 3). The four variants identified in our study locate to 
Domains I and III, both of which are involved in Hsp90 binding. Domain I has PPIase 
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is mediated partly by binding to immunophilins
5,35
. The N125S variant is located in the 
PPIase active site, suggesting a potentially useful functional assay for mutational effect. It 
was notable that this variant and indeed each of the other variants identified, all showed 
profound loss of activity, indicating either structural or conformational disturbance to the 
PPIase active site.  
Domain III includes three TPRs which mediate protein-protein interactions involved 
in FKBP52-regulated cellular functions
36
. FKBP52 associates with Hsp90 in steroid receptor 
complexes, suggesting a role in the nuclear translocation of steroid hormone receptors such as 
the glucocorticoid receptor (GR). The hormone-free GR is localized in the cytoplasm and it 
translocates to the nucleus after steroid binding
37
. Studies suggest that the Hsp90-based 
chaperone system and the Hsp90-binidng FKBP52 are involved in the movement of the GR 
to the nucleus
38
. In fact, in vivo studies have shown that FKBP52 is incorporated into steroid 
receptor complexes by binding to Hsp90 via the TPR domain and it then facilitates 
translocation of the activated receptor to the nucleus via PPIase domain binding to 
dynein
18,39
. In addition, the importance of the role of FKBP4 has been emphasized in the 
horse embryo
40
, as well as in the human embryo, as FKBP52 protein levels were decreased in 
placenta of RPL patients suggesting an association with pregnancy loss
41
.  
The four FKBP4 variants described here were all identified in RPL Asian patients but 
were not present in a Bangladeshi fertile control cohort. Neverthless, all four variants were 
present as rare variants in the ExAC/gnomAD databases, mainly in the South Asian 
population. The A16E mutation was heterozygous in four South Asian females, R399Q was 
heterozygous in six South Asian female and one homozygote, Q381L was heterozygous in 
two South Asian females, while N125S was heterozygous in one African and one Latino 
female. These databases contained data from more than 57,000 females but no  information is 
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determine if any of these variant carrying females might have experienced miscarriages. 
There remains a possibility that this apparent population bias might suggest an Asian specific 
cause of RPL. We don’t currently have any compelling explanation for this other than the fact 
that the particular variants identified do appear to be largely Asian-specific. The lack of 
likely-causal European variants identified in this study may simply reflect the relatively small 
size of the cohort investigated and suggests an urgent need for a larger study population to be 
investigated.  
  Our study identified missense variants at conserved residues within two functional 
domains of FKBP52. The variants were predicted to have damaging effects to structure-
function properties and were shown to abrogate PPIase activity in a cell based assay. Coupled 
to evidence from mouse studies demonstrating the importance of Fkbp52 for embryo 
implantation, we suggest a potentially important role for this gene in the maintenance of 
pregnancy in humans, which requires further investigation. The nature of the immunophilin 
FK506 binding protein and the functional role of the encoded prolyl isomerase may present 
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MATERIALS AND METHODS 
Ethics 
DNA samples and medical records for this study were obtained from the Recurrent 
Miscarriage Clinic at St Mary’s Hospital, part of Imperial College Healthcare NHS Trust, 
which contains blood samples from over seven thousand women who agreed to participate in 
research with signed, informed consent. The study was approved by the Imperial College 
Hospital Ethics Committee (REC ref EC0081).  
Patient samples 
Blood samples were available from the RPL patient (proband) who had 29 
miscarriages, her third husband and her two brothers. Buccal swabs were collected from the 
patient’s parents. The RPL cohort studied consisted of 100 Asian female patients and 120 
White European female patients. These patients were idiopathic and to be included in the 
study must have had three or more miscarriages and no live births. The average age of the 
Asian and European patient cohorts at the time of sample collection was 33.2 ± 5 and 35.3 ± 
4.6 years, respectively. DNA samples from 100 Bangladeshi controls had no history of RPL 
and had at least one live birth.  
Whole-exome sequencing 
Whole-exome sequencing was performed on DNA derived from peripheral blood with 
GOSgene (UCL genomic partner http://www.ucl.ac.uk/ich/services/lab-services/gosgene). 
Genomic DNA was subjected to array capture with the SureSelect Human Exon Kit v.4 
(Agilent Technologies) according to the manufacturer’s instructions. Adapters were ligated, 
and paired-end sequencing was performed on an Illumina HiSeq 2000, which generated 2 x 
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sequence was covered at least 10 and 30 times, respectively. Sequencing reads were aligned 
to the reference human genome (GRCh37/hg19, UCSC Genome Browser) with the BWA 
consensus, variant bases were called with GATK and variants were annotated with 
ANNOVAR.  
Ingenuity Variant Analysis   
Candidate gene variants were identified using Ingenuity Variant Analysis (Quiagen 
Bioinformatics). We applied a dominant model considering the RPL patient to be an affected 
individual with her two brothers and husband as unaffected.  Recessive inheritance was 
considered unlikely due to the continued recurrence of miscarriages with two further, 
unrelated partners. Four Asian females were used as additional unaffected controls. The 
following filters were used to choose variants that were present in the patient but not present 
in the remaining samples: Common variants filter: excluded variants with an allele frequency 
of at least 1% in both the 1000 Genomes Projectand public Complete Genomics genomes. 
We considered as rare variants those with a frequency below 1% in public databases (ExAC, 
Exome Variant Server and 1000 Genomes); Predicted deleterious filter: kept variants that are 
experimentally observed to be pathogenic, likely pathogenic or uncertain significance; 
Genetic Analysis filter: kept variants that are homozygous, heterozygous compound 
heterozygous, haploinsufficient and occur in the case sample and excluded variants that occur 
in at least 1 of the control samples; Biological context filter: kept only variants that are 
known or predicted to affect genes implicated in the following diseases, processes, pathways 
or phenotypes: implantation, thrombosis or miscarriage. 
Sanger sequencing 
Sanger sequencing on FKBP4 and SERPINB2 was used to confirm WES variants and 
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Table 2 for primers). Exons were amplified using Taq DNA polymerase (Bioline) and 
sequencing was performed using BigDye terminator v1.1 (Life technologies). Sequencing 
reactions were run on an ABI ABI 3730xl DNA Analyzer and the read-out was then analysed 
with Sequencher™ v4.8 (Gene Codes Corporation). 
In silico prediction of variant pathogenicity 
The pathogenicity scores of the FKBP4 and SERPINB2 variants identified was 
predicted using the online tools SIFT (http://sift.jcvi.org/), nsSNP Analyzer 
(http://snpanalyzer.uthsc.edu/), Polyphen2 (http://genetics.bwh.harvard. edu/pph2/), Mutation 
Taster (http://www.mutationtaster.org/), Variant Effect Predictor 
(http://www.ensembl.org/Tools/VEP) and PROVEAN (http://provean.jcvi.org/index.php), 
applied with standard procedures and settings.  
Structure analysis and evolutionary conservation 
UCSF Chimera was used for visualization and alignment of FKBP52 structures, and 
to carry out residue interaction studies. ConSurf server was used to calculate evolutionary 
conservation of amino acids and map the conservation scores onto the structures. The mapped 
scores were then used to color the structures in Chimera.       
Constructs, Cell culture and transfection 
A WT full length FKBP52-FLAG plasmid and matching empty vector were provided 
by Dr Felix Hausch (Max Planck Institute of Psychiatry, Department of Chemical Genomics, 
Munich, Germany). The p.A16E, p.N125S, p.Q381L and p.R399Q variants were introduced 
using site-directed mutagenesis using the Quickchange II XL site-directed mutagenesis kit 
according to manufacturer’s instructions. Primers used for mutagenesis are available on 
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HEK293 cells were cultured in 10% FBS (Thermo Fisher, #10500064) prepared in DMEM 
(Thermo Fisher, #41966052) supplemented with penicillin and streptomycin (Thermo Fisher, 
#15140122). Cells were passaged with 0.25% Trypsin-EDTA (Thermo Fisher, #25200056) 
when they approached 80-90% confluency. Transfections were performed in a T25 flask 
using FuGene (Promega) according to the manufacturer’s instructions. 
PPIase activity 
The effect of each variant was assayed compared to WT and empty vector controls by 
monitoring the peptidyl-prolyl cis-trans isomerase (PPIase) activity of FKBP52. Essentially, 
48 hours following transfection of constructs (in triplicate), proteins were extracted from cells 
using standard procedures. Pellets were immediately frozen and sent to Eurofins Selcia Drug 
Discovery (Ongar, Essex, UK) where PPIase activity was measured spectrophotometically 
according to the method described in Janowski et al (1997)
9
.  A two-tailed, equal variance t-
test was used to examine statistical significance. Protein loading was confirmed by western 
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Figure 1: Family pedigree.  
The affected patient (II-3) had a total of 29 early miscarriages: 17 with her first husband (II-
1), five with her second husband (II-2) and seven with her third husband (II-4). Her two 
brothers (II-5 and II-7) had each two successful pregnancies. Her mother (I-2) had suffered 
three late miscarriages. Blood was collected from individuals marked with a “b” and buccal 
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Figure 2: Analysis of variants in FKBP4.  
A) Four missense variants were identified in four RPL patients. Both WT and mutant DNA 
sequence is displayed. Patient 1 (exome patient) had a mutation in exon 1 (c.47C>A; 
p.A16E). Patient 2 had a mutation in exon 3 (c.374A>G; p.N125S). Patients 3 and 4 each had 
a mutation in exon 9 (c.1142A>T; p.Q381L) and (c.1196G>A; p.R399Q). B) In silico 
predictions were used to predict pathogenicity of the four variants (LoF: Loss of Function). 
C) Amino acid conservation of the human FKBP52 protein and its orthologues in selected 
species. The aa residues at each of the identified variants (p.A16E, p.N125S, p.Q381L and 
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Figure 3: Graphical view of FKBP4 chromosomal position, gene structure and protein 
product, along with the distribution of four identified missense variants.  
FKBP4 maps to chromosomal region 12p13.33 and encodes a 10-exon transcript that spans 
approximately 10 kb of genomic DNA
16,17
. Grey boxes represent exons and black lines 
represent introns. The translated protein (459 amino acids) includes four individual and 
functional domains
18
. Domain I or FK1 includes the N-terminal portion of FKBP52 and 
consists of the FK506-binding site, which contains peptidyl-prolyl cis-trans isomerase 
(PPIase) activity
19
. Domain II or FK2 contains the PPIase-like domain, which shares 32% 
sequence homology to domain I, but exhibits no PPIase activity
18,19
. Domain II contains an 
ATP/GTP binding sequence
20
. Domain III possesses three tetratricopeptide repeat (TPR) 
domains that serve as binding sites for 90-kDa heat shock protein (Hsp90), which is also a 
component of the steroid receptor complexes
21
. The region located between aa 267 and 400 is 
required for tubulin binding
22
. Domain IV is the C-terminal domain of FKBP52 and it is a 
short helix that contains a putative binding site for calmodulin
23
. Black crosses indicate the 
position and protein variant of each mutation identified in the four RPL patients. The 
structure of the FKBP4 transcript and organization of the protein domains are not drawn to 
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Figure 4: Structure analysis of FKBP52 variants.  
a) Hydrogen bond between N125 and S115 in the FK1 domain of FKBP52 in the unbound 
form (PDB ID: 1Q1C 
28
). Crystal structure of FKBP52 (magenta) bound to Rapamycin 
(orange) and FRB domain of mTOR (blue) (PDB ID: 4DRJ 
40
) is superposed. N125S 
mutation can result in the loss of hydrogen bond interaction with S115, which appears to be 
important for conformation changes involved in the active site loop (residues 112-127). b) 
Conservation of residues in the TPR domain and C-terminal helix. Red to Blue shows 
increasing degree of conservation. Both R399 and Q381 are highly conserved among 
FKBP52 family and are surface exposed in the structure, strongly suggesting a role in 
interactions with binding partners. c) Crystal structure of C-terminal domains (FK2, TPR and 
C-term extension) of FKBP52 (PDB ID: 1P5Q 
28
). R399Q results in the loss of a positive 
charge at the surface while Q381L replaces a polar side chain with a hydrophobic group 
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Figure 5: PPIase activity of FKBP4 constructs.  
a) HEK293 cells were transiently transfected with constructs containing WT or mutant full-
length FKBP4 cDNAs, empty vector and Fugene reagent transfection only controls. 
Following 48 hour incubation, proteins were extracted and measured for PPIase activity. * = 
p<0.002; **= p<0.001. b) Western blot showing protein loading using anti-FLAG (top) and 
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APLS Antiphospholipid syndrome 
FKBP4 FK506 binding protein 4 
FVL Factor V Leiden  
GR Glucocorticoid receptor 
Hsp90 Heat shock protein 90 
LA Lupus anticoagulant 
LBD Ligand binding domain 
LoF Loss of function 
PPIase Peptidyl-prolyl cis-trans isomerase 
PR Progesterone receptor 
PRDX6 Peroxiredoxin-6 
RPL Recurrent pregnancy loss 
SERPINB2 Serpin peptidase inhibitor clade b2 
TPR Tetratricopeptide 
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